Enanta Pharmaceuticals (ENTA) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ENTA filings

Are insiders buying or selling Enanta Pharmaceuticals Inc (ENTA) stock?

Neither. Enanta Pharmaceuticals Inc (ENTA) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ENTA recently?

None. No member of Congress disclosed a ENTA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ENTA smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Filings could not be loaded.

18 funds hold a position.

Questions about ENTA filings

Are insiders buying or selling Enanta Pharmaceuticals Inc (ENTA) stock?

Neither. Enanta Pharmaceuticals Inc (ENTA) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ENTA recently?

None. No member of Congress disclosed a ENTA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ENTA smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 10, 2026

Earnings came in 81.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 10, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.67-81.08% miss

-$0.37 expected

Revenue

$14.4M

SEC filing

Next report

Estimated report: Nov 16, 2026, in 2 days

Estimates as of Nov 13, 2026

EPS expected

-$0.77

-$0.95 to -$0.55

Revenue expected

$15.7M

5 analysts

Last 30 days

0up2down

Analysts cutting estimates

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 10, 2026	-$0.67est. -$0.37	-81.08%miss	$14.4MSEC filing	-21.6%from $18.3M
Mar 31, 2026Reported May 11, 2026	-$0.45est. -$0.57	+21.05%beat	$17.2MSEC filing	+15.0%from $14.9M
Dec 31, 2025Reported Feb 9, 2026	-$0.42est. -$0.88	+52.27%beat	$18.6MSEC filing	+9.8%from $17.0M
Sep 30, 2025Reported Nov 17, 2025	-$0.87est. -$1.01	+13.86%beat	$65.3M · FYSEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 11, 2025	-$0.85est. -$0.88	+3.41%beat	$18.3MSEC filing	+1.9%from $18.0M
Mar 31, 2025Reported May 12, 2025	-$1.06est. -$1.14	+7.02%beat	$14.9MSEC filing	-12.5%from $17.1M
Dec 31, 2024Reported Feb 10, 2025	-$1.05est. -$1.35	+22.22%beat	$17.0MSEC filing	-5.8%from $18.0M
Sep 30, 2024Reported Nov 25, 2024	-$1.36est. -$0.92	-47.83%miss	$67.6M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $11.35
High: $11.70
Low: $11.17
Prev close: $11.22
52-wk high: $17.15
52-wk low: $10.05
Mkt cap: $326.2M
ROE: -70.1%
Fwd P/E: 44.0x
Beta: 0.76
P/S: 5.0x
P/B: 3.3x
Profit margin: -96.9%
Op margin: -90.0%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -96.9%
Forward P/E: 44.05
Market cap: $326M

Valuation

P/S5.00
P/B3.34

Quality

Operating margin-90.0%
ROE-70.1%
ROA-12.3%

Growth

Beta0.76

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

50balanced

20D volatility

60%annualized

52-week range

$11.60

$10.05$17.15

20D support

$10.05recent floor

20D resistance

$12.39recent ceiling

Returns

5D +8.9%20D +3.8%60D -12.8%

Price vs moving averages

SMA20 +3.3%SMA50 -3.9%SMA200 -11.6%

Volume pace

0.95xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 10, 2026

-$0.67est. -$0.37

-81.08%

$14.4MSEC filing

-21.6%from $18.3M

Mar 31, 2026May 11, 2026

-$0.45est. -$0.57

+21.05%

$17.2MSEC filing

+15.0%from $14.9M

Dec 31, 2025Feb 9, 2026

-$0.42est. -$0.88

+52.27%

$18.6MSEC filing

+9.8%from $17.0M

Sep 30, 2025Nov 17, 2025

-$0.87est. -$1.01

+13.86%

$65.3M · FYSEC filing

No year-ago quarter

Jun 30, 2025Aug 11, 2025

-$0.85est. -$0.88

+3.41%

$18.3MSEC filing

+1.9%from $18.0M

Mar 31, 2025May 12, 2025

-$1.06est. -$1.14

+7.02%

$14.9MSEC filing

-12.5%from $17.1M

Dec 31, 2024Feb 10, 2025

-$1.05est. -$1.35

+22.22%

$17.0MSEC filing

-5.8%from $18.0M

Sep 30, 2024Nov 25, 2024

-$1.36est. -$0.92

-47.83%

$67.6M · FYSEC filing

No year-ago quarter

Enanta Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about ENTA filings

Questions about ENTA filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 81.1% below what analysts expected.

Estimated report: Nov 16, 2026, in 2 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Enanta Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about ENTA filings

Questions about ENTA filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 81.1% below what analysts expected.

Estimated report: Nov 16, 2026, in 2 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Enanta Pharmaceuticals Inc

Overview

Questions about ENTA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Enanta Pharmaceuticals Inc

Overview

Questions about ENTA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.